Ullmann Wealth Partners Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Buy
994
+32
+3% +$37.8K 0.1% 75
2026
Q2
$1.15M Buy
962
+132
+16% +$135K 0.1% 76
2026
Q1
$764K Buy
830
+170
+26% +$172K 0.08% 82
2025
Q4
$569K Buy
660
+22
+3% +$21K 0.06% 96
2025
Q3
$487K Buy
638
+97
+18% +$72.2K 0.05% 102
2025
Q2
$422K Sell
541
-53
-9% -$41.2K 0.05% 103
2025
Q1
$491K Buy
594
+109
+22% +$90.7K 0.07% 90
2024
Q4
$374K Sell
485
-18
-4% -$14.9K 0.05% 104
2024
Q3
$446K Buy
503
+9
+2% +$8.09K 0.06% 94
2024
Q2
$447K Buy
494
+76
+18% +$60.8K 0.06% 80
2024
Q1
$325K Buy
+418
New +$297K 0.05% 88

Other funds holding LLY

Ullmann Wealth Partners Group's LLY Position: Q3 2026 in Review

Ullmann Wealth Partners Group increased its Eli Lilly (LLY) stake by 3.3% in Q3 2026, buying an estimated $37.8K and bringing the position to 994 shares worth $1.15M. The position accounts for 0.1% of the portfolio, ranked #75.

Ullmann Wealth Partners Group first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.15M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Ullmann Wealth Partners Group held 994 shares of Eli Lilly worth $1.15M as of Q3 2026.
  • Ullmann Wealth Partners Group bought 32 Eli Lilly shares in Q3 2026, an estimated $37.8K.
  • Eli Lilly made up 0.1% of Ullmann Wealth Partners Group's portfolio in Q3 2026, its #75 holding.
  • Ullmann Wealth Partners Group first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • Ullmann Wealth Partners Group's Eli Lilly position peaked at $1.15M in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ullmann Wealth Partners Group's 13F filing for Q3 2026, filed 2 Nov 2026.